However, CRC cells often evade immune surveillance by inhibiting IFN production and function through down-regulation of IFN receptors (e.g., IFNAR1) or interfering with innate immune receptor signaling pathways (e.g., cGAS-STING, TLR, and RIG-I) (12–18). The gene discussed is STING1; the disease is colorectal carcinoma.